Market Overview

Stocks Hitting 52-Week Lows

Related MNTA
Momenta Pharmaceuticals Announces Acceptance Of A Clinical Trial Application In Europe for M923, A Biosimilar Version Of Humira
Stocks Hitting 52-Week Lows
Related LTBR
Lightbridge Announces $5.04M Registered Direct Offering
Worst Performing Industries For November 10, 2014

Momenta Pharmaceuticals (NASDAQ: MNTA) shares lost 2.52% to create a new 52-week low of $10.06. Momenta Pharmaceuticals reported that its presentation at the Deutsche Bank 2012 dbAccess BioFEST will be webcast on December 4.

Lightbridge (NASDAQ: LTBR) shares fell 9.18% to touch a new 52-week low of $1.09. Lightbridge's trailing-twelve-month operating margin is -158.56%.

Genetic Technologies Limited (NASDAQ: GENE) shares dropped 19.20% to create a new 52-week low of $2.02. Genetic Technologies announced the resignation of its CEO, Dr. Paul MacLeman.

Sony (NYSE: SNE) shares declined 1.33% to create a new 52-week low of $9.61. Sony shares have dropped 46.04% over the past 52 weeks, while the S&P 500 index has gained 12.19% in the same period.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

 

Related Articles (GENE + LTBR)

Around the Web, We're Loving...

Get Benzinga's Newsletters